To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.

This bill requires state Medicaid programs to monitor (through their drug utilization review programs) the use of antipsychotic medications by adults, particularly individuals over the age of 65, individuals who receive home- and community-based services, and individuals who are in institutional care settings (e.g., nursing facilities). (States are currently only required to monitor the use of antipsychotic medications by children.)